Iran Daru (XTEH:IRDR1) Interest Expense : IRR Mil (TTM As of . 20)

View and export this data going back to 1990. Start your Free Trial

What is Iran Daru Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Iran Daru's interest expense for the six months ended in . 20 was IRR 0.00 Mil. Iran Daru does not have enough years/quarters to calculate its interest expense for the trailing twelve months (TTM) ended in . 20.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Iran Daru's Operating Income for the six months ended in . 20 was IRR 0.00 Mil. Iran Daru's Interest Expense for the six months ended in . 20 was IRR 0.00 Mil. Iran Daru did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Iran Daru Interest Expense Historical Data

The historical data trend for Iran Daru's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Iran Daru Interest Expense Chart

Iran Daru Annual Data

Trend

Interest Expense

Iran Daru Semi-Annual Data

Interest Expense

Iran Daru Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Iran Daru (XTEH:IRDR1) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Iran Daru's Interest Expense for the six months ended in . 20 was IRR0.00 Mil. Its Operating Income for the six months ended in . 20 was IRR0.00 Mil. And its Long-Term Debt & Capital Lease Obligation for the six months ended in . 20 was IRR0.00 Mil.

Iran Daru's Interest Coverage for the quarter that ended in . 20 is calculated as

Iran Daru had no long-term debt ⁽¹⁾.

The higher the ratio, the stronger the company's financial strength is.

Iran Daru (XTEH:IRDR1) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Iran Daru (XTEH:IRDR1) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

Ayatollah Saeedi Highway, End Of Kermani Street, Moallem Boulevard, Tehran, IRN, 1371658111

Website

https://www.irandaru.com

Iran Daru is a pharmaceutical company based in Iran. It manufactures and sells pharmaceutical products for antibiotics, cardiovascular agents, and local anesthetic agents. The company manufactures products in three main dosage form categories namely solid, semi-solid, and liquid including tablets, capsules, pellets, sachets, gels, creams, ointments (sterile and non-sterile), spray solutions, and syrups. Products offered by Iran Daru include Diclofenac Potassium, Biotin 5 mg, Tetracycline, Folic acid, Meloxicam, Acetaminophen and Caffeine, and Levocetirizine dihydrochloride, among others. It also exports its products to other countries.

Iran Daru (XTEH:IRDR1) Headlines

No Headlines